Income Statement (TTM)
BioNexus Gene Lab Corp. Income Statement shows changes in income and expenses over a period of time. Income Statement data includes Sales and Revenue, Gross Profit, Research and Development (R&D), Selling, General and Administrative Expense (SG&A), Operating Income, Income Tax Expense, Interest Expense, Non-Operating Income, Earnings per Share (EPS), and Shares Outstanding.
All numbers are times 1,000,000 except per share units.
2020 09-30 |
2020 12-31 |
2021 03-31 |
2021 06-30 |
2021 09-30 |
2021 12-31 |
2022 03-31 |
2022 06-30 |
2022 09-30 |
2022 12-31 |
2023 03-31 |
2023 06-30 |
2023 09-30 |
2023 12-31 |
2024 03-31 |
2024 06-30 |
2024 09-30 |
2024 12-31 |
2025 03-31 |
2025 06-30 |
|
---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|
Revenue | 7 | 11 | 12 | 14 | 14 | 13 | 13 | 12 | 11 | 11 | 10 | 10 | 10 | 10 | 10 | 9 | 9 | 10 | 9 | 10 |
Change (%) | 55.66 | 3.33 | 16.90 | 3.52 | -6.18 | -3.14 | -4.69 | -8.11 | -3.58 | -5.96 | 0.80 | -0.21 | -5.48 | 0.05 | -6.06 | 0.84 | 2.71 | -2.57 | 3.08 | |
% of Revenue | 100.00 | 100.00 | 100.00 | 100.00 | 100.00 | 100.00 | 100.00 | 100.00 | 100.00 | 100.00 | 100.00 | 100.00 | 100.00 | 100.00 | 100.00 | 100.00 | 100.00 | 100.00 | 100.00 | 100.00 |
Cost Of Sales | 6 | 10 | 10 | 12 | 12 | 11 | 11 | 10 | 10 | 10 | 9 | 9 | 9 | 8 | 8 | 8 | 8 | 8 | 8 | 8 |
Change (%) | 62.63 | 4.67 | 16.60 | 2.27 | -8.08 | -1.75 | -3.70 | -5.34 | -2.69 | -6.87 | 0.07 | -0.85 | -5.53 | 0.10 | -6.41 | 1.32 | 2.60 | -2.72 | 2.58 | |
% of Revenue | 81.26 | 84.90 | 86.01 | 85.79 | 84.75 | 83.04 | 84.23 | 85.11 | 87.67 | 88.48 | 87.63 | 86.99 | 86.44 | 86.39 | 86.44 | 86.12 | 86.53 | 86.44 | 86.32 | 85.89 |
Gross Operating Profit | 1 | 2 | 2 | 2 | 2 | 2 | 2 | 2 | 1 | 1 | 1 | 1 | 1 | 1 | 1 | 1 | 1 | 1 | 1 | 1 |
Change (%) | 25.43 | -4.23 | 18.72 | 11.12 | 4.33 | -9.98 | -9.98 | -23.96 | -9.87 | 1.00 | 5.96 | 4.07 | -5.18 | -0.29 | -3.85 | -2.18 | 3.42 | -1.67 | 6.25 | |
% of Revenue | 18.74 | 15.10 | 13.99 | 14.21 | 15.25 | 16.96 | 15.77 | 14.89 | 12.33 | 11.52 | 12.37 | 13.01 | 13.56 | 13.61 | 13.56 | 13.88 | 13.47 | 13.56 | 13.68 | 14.11 |
SG&A | 1 | 1 | 1 | 1 | 2 | 1 | 1 | 1 | 1 | 2 | 2 | 2 | 5 | 4 | 4 | 4 | 3 | 3 | 4 | 5 |
Change (%) | 36.68 | -1.92 | 12.32 | 8.16 | -19.56 | 5.10 | 5.71 | 0.35 | 21.41 | 9.76 | 18.56 | 118.34 | -11.39 | 0.49 | -15.18 | -25.66 | 15.95 | 12.17 | 25.44 | |
% of Revenue | 13.33 | 11.70 | 11.11 | 10.67 | 11.15 | 9.56 | 10.38 | 11.51 | 12.57 | 15.83 | 18.47 | 21.73 | 47.54 | 44.56 | 44.76 | 40.41 | 29.79 | 33.63 | 38.72 | 47.12 |
R&D | 0 | 0 | 0 | 0 | 0 | 0 | 0 | |||||||||||||
Change (%) | 20.87 | 12.34 | 0.00 | -36.36 | 1.40 | 9.05 | ||||||||||||||
% of Revenue | 0.56 | 0.68 | 0.81 | 0.81 | 0.50 | 0.52 | 0.55 | |||||||||||||
OpEx | 7 | 11 | 11 | 13 | 13 | 12 | 12 | 12 | 11 | 11 | 11 | 11 | 13 | 13 | 13 | 12 | 11 | 11 | 12 | 13 |
Change (%) | 58.59 | 3.73 | 16.16 | 2.68 | -8.10 | -0.92 | -2.70 | -4.75 | -1.35 | -5.08 | 2.04 | 22.61 | -3.27 | 0.92 | -7.90 | -9.36 | 5.72 | 1.57 | 9.19 | |
% of Revenue | 93.27 | 95.02 | 95.39 | 94.79 | 94.02 | 92.10 | 94.22 | 96.19 | 99.71 | 102.02 | 102.98 | 104.25 | 128.09 | 131.09 | 132.23 | 129.63 | 116.53 | 119.95 | 125.05 | 132.46 |
Operating Income | 0 | 1 | 1 | 1 | 1 | 1 | 1 | 0 | 0 | -0 | -0 | -0 | -3 | -3 | -3 | -3 | -2 | -2 | -2 | -3 |
Change (%) | 15.03 | -4.32 | 32.20 | 18.87 | 23.87 | -29.12 | -37.14 | -93.08 | -777.05 | 38.69 | 43.89 | 559.71 | 4.62 | 3.72 | -13.62 | -43.76 | 23.98 | 22.31 | 33.59 | |
% of Revenue | 6.73 | 4.98 | 4.61 | 5.21 | 5.98 | 7.90 | 5.78 | 3.81 | 0.29 | -2.02 | -2.98 | -4.25 | -28.09 | -31.09 | -32.23 | -29.63 | -16.53 | -19.95 | -25.05 | -32.46 |
Interest Expense | -0 | -0 | -0 | -0 | -0 | -0 | -0 | -0 | -0 | -0 | -0 | -0 | -0 | -0 | -0 | -0 | -0 | -0 | -0 | -0 |
Change (%) | -57.22 | 2.93 | 18.02 | -1.50 | -4.17 | -0.25 | -8.96 | -0.66 | 6.63 | -7.06 | 6.23 | 17.75 | -3.99 | 15.91 | 8.91 | 11.00 | 8.35 | 1.17 | 1.87 | |
% of Revenue | -0.36 | -0.10 | -0.10 | -0.10 | -0.10 | -0.10 | -0.10 | -0.10 | -0.10 | -0.11 | -0.11 | -0.12 | -0.14 | -0.14 | -0.17 | -0.19 | -0.21 | -0.22 | -0.23 | -0.23 |
Net Income | 1 | 1 | 0 | 0 | 0 | 1 | 0 | 0 | -0 | -0 | -0 | -1 | -3 | -3 | -3 | -2 | -1 | -2 | -2 | -3 |
Change (%) | -6.94 | -66.80 | 17.65 | 14.24 | 53.96 | -42.80 | -38.83 | -141.74 | 224.33 | 24.20 | 27.28 | 449.95 | -15.04 | 1.32 | -17.21 | -57.31 | 69.75 | 32.51 | 38.49 | |
% of Revenue | 16.07 | 9.61 | 3.09 | 3.11 | 3.43 | 5.62 | 3.32 | 2.13 | -0.97 | -3.26 | -4.30 | -5.43 | -29.94 | -26.91 | -27.25 | -24.02 | -10.17 | -16.81 | -22.86 | -30.71 |
Source: Capital IQ